| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 70.627 | 77.260 | 74.889 | 71.505 | 75.164 | 70.843 | 69.719 | 81.644 | 89.264 | 86.490 |
| Total Income - EUR | 71.571 | 78.053 | 75.515 | 71.905 | 76.024 | 72.145 | 70.001 | 81.644 | 92.684 | 87.200 |
| Total Expenses - EUR | 64.180 | 70.998 | 71.067 | 68.826 | 70.679 | 65.872 | 62.077 | 80.077 | 87.965 | 79.587 |
| Gross Profit/Loss - EUR | 7.390 | 7.054 | 4.448 | 3.079 | 5.345 | 6.272 | 7.924 | 1.567 | 4.719 | 7.613 |
| Net Profit/Loss - EUR | 6.190 | 6.274 | 3.693 | 2.360 | 4.585 | 5.619 | 7.385 | 767 | 3.903 | 5.401 |
| Employees | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 1 |
Check the financial reports for the company - Fitofarm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.978 | 1.722 | 1.463 | 1.209 | 963 | 727 | 497 | 285 | 71 | 0 |
| Current Assets | 24.214 | 25.177 | 22.412 | 20.707 | 23.497 | 25.040 | 26.349 | 21.817 | 18.095 | 19.191 |
| Inventories | 10.669 | 14.046 | 12.635 | 11.906 | 8.329 | 8.983 | 10.021 | 14.990 | 11.948 | 14.728 |
| Receivables | 610 | 602 | 362 | 355 | 348 | 342 | 246 | 503 | 54 | 206 |
| Cash | 12.936 | 10.529 | 9.415 | 8.446 | 14.820 | 15.715 | 16.082 | 6.324 | 6.094 | 4.257 |
| Shareholders Funds | 17.577 | 23.672 | 20.796 | 19.149 | 21.056 | 21.778 | 23.185 | 10.032 | 13.905 | 13.197 |
| Social Capital | 45 | 45 | 44 | 43 | 53 | 52 | 51 | 51 | 51 | 50 |
| Debts | 8.615 | 3.228 | 3.093 | 2.766 | 3.404 | 3.990 | 3.662 | 12.070 | 4.262 | 5.994 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4776 - 4776" | |||||||||
| CAEN Financial Year |
4776
|
|||||||||
Comments - Fitofarm S.r.l.